PTSM: Pharmaceutical Technology Sourcing and Management-08-07-2013

A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

The industry may not be ready for India and China as regulatory issues emerge.

Pfizer, Merck, Sanofi, and AstraZeneca are among the companies reporting revenue declines from generic-drug incursion. A look at what the companies are doing to stimulate growth.

Contract service providers expand capabilities in API and finished product manufacturing to meet demand for high-potency drugs